Misplaced Pages

Verinurad

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (December 2023)
Pharmaceutical compound
Verinurad
Clinical data
Other namesRDEA-3170; RDEA3170
Legal status
Legal status
  • Investigational
Identifiers
IUPAC name
  • 2-sulfanyl-2-methylpropanoic acid
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC20H16N2O2S
Molar mass348.42 g·mol
3D model (JSmol)
SMILES
  • CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N
InChI
  • InChI=1S/C20H16N2O2S/c1-20(2,19(23)24)25-18-9-10-22-12-17(18)16-8-7-13(11-21)14-5-3-4-6-15(14)16/h3-10,12H,1-2H3,(H,23,24)
  • Key:YYBOLPLTQDKXPM-UHFFFAOYSA-N

Verinurad is a selective URAT1 inhibitor developed for gout and heart failure by AstraZeneca.

References

  1. Johansson, Susanne; Han, David; Hunt, Thomas; Björck, Karin; Florica, Delia; Gillen, Michael; Hall, Jesse; Erlandsson, Fredrik (June 2022). "Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non-Asian participants". Pharmacology Research & Perspectives. 10 (3): e00929. doi:10.1002/prp2.929. PMC 9121888. PMID 35593744.
  2. Fitz-Patrick, David; Roberson, Kent; Niwa, Kiyoshi; Fujimura, Takabumi; Mori, Koji; Hall, Jesse; Yan, Xiaohong; Shen, Zancong; Liu, Sha; Ito, Yasushi; Baumgartner, Scott (2 November 2019). "Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials". Modern Rheumatology. 29 (6): 1042–1052. doi:10.1080/14397595.2018.1538003. PMID 30334639. S2CID 52988677.
  3. Tan, Philip K.; Liu, Sha; Gunic, Esmir; Miner, Jeffrey N. (6 April 2017). "Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout". Scientific Reports. 7 (1): 665. Bibcode:2017NatSR...7..665T. doi:10.1038/s41598-017-00706-7. ISSN 2045-2322. PMC 5429603. PMID 28386072.
Categories: